🔗 Share this article

Acclaimed R&B singer D’Angelo died on the fourteenth of October at age 51 after a private battle with pancreatic malignancy.

“The brilliant light of our family has faded away for us in the present world,” his relatives confirmed. “After a prolonged and courageous battle with cancer, we are heartbroken to announce that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his pioneering modern soul style and partnerships with renowned musicians.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album reached No. 4 on the R&B charts, earned platinum status soon after, and earned several award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his music career into the stratosphere. The record premiered at the top spot on both Billboard’s Top R&B Albums chart and the main album chart. He won two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a reluctant one, in the public consciousness. The intimate portrayal showed the artist, famously bare to his waist, singing directly into the lens.

D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was involved in a severe car crash that put him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with another No. 1 debut on the R&B chart and a award for Best R&B Album.

Again, in his own enigmatic fashion, D’Angelo had limited public outings in the following years.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his performance was canceled, citing an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s health in the weeks before his death, he had reportedly been hospitalized for months and in hospice for a fortnight.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic cancer, one of the most deadly and hardest to prevent forms of the illness, on a brilliant talent whose existence was ended too soon.

“We are saddened that he can only leave dear memories with his family, but we are forever thankful for the legacy of deeply emotional songs he has left us,” his kin expressed.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic cancer impacts the digestive organ, a small organ that produces the hormone insulin and is vital in breaking down food, among additional roles. The position and dimensions of the organ in the human system make it more difficult to identify cancer.

Although this cancer makes up only about 3% of malignancy cases each year in the U.S., it is responsible for seven percent of cancer deaths.

Almost seventy thousand individuals will be diagnosed with this condition and roughly fifty-two thousand will die of the illness in the year 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and ineffective therapies, and a narrow opportunity to make a significant difference on the well-being of people,” said a cancer specialist.

Since pancreatic cancer seldom produces early symptoms, it’s frequently identified only after the condition is advanced. Although a patient has indicators they are usually nonspecific and may be mistaken for a several everyday ailments.

“As of yet, there is no effective method to identify pancreatic cancer in the early stages, except for paying attention to physical changes and consulting your physician if there are unfamiliar signs,” said a health expert.

Common symptoms of this disease include:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• diarrhea
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s demise is an outlier, as this malignancy is most common in adults in the 65 to 75 range. However, numerous malignancies, such as this type, have become more common among younger adults.

“Pancreatic cancer diagnosed prior to fifty is deemed rare, yet alarmingly, doctors are noticing a rising count of younger individuals affected by this disease,” said a specialist.

Genetic Background Impacts Cancer Risk

In the absence of effective screening tools for pancreatic cancer, professionals stressed the importance of knowing your relatives’ health background. Some contributing elements, such as smoking and obesity also have an influence in the development of pancreatic cancer.

Black individuals have the greatest occurrence of pancreatic cancer in the United States and are more prone to be diagnosed with inoperable cancer.

“The first step toward lowering one’s risk of this condition is understanding individual susceptibility. People should review their family history, genetic background, and health issues, such as diabetes, long-term pancreas inflammation, or overweight that may raise their vulnerability,” said a specialist.

Inherited genetic risk factors are associated with as much as 10% of all this malignancy cases. If someone in your household has had this disease, you may want to consider genetic testing.

“For people with a relative’s background of pancreatic cancer or those carrying elevated risk genetic mutations, checking may involve sophisticated scans such as MRI scans or endoscopic ultrasound (EUS) to find initial alterations in the organ,” he clarified.

For those wishing to lower their chance, lifestyle changes may have an effect. The best step you can take to reduce your susceptibility of pancreatic cancer is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Heavy drinking is linked to pancreas inflammation, a contributing element for this malignancy, so limiting or avoiding alcohol may assist reduce your risk.

Controlling your body mass or losing weight may also aid reduce your risk. Individuals with excess weight are twenty percent more prone to develop pancreatic cancer. This malignancy also occurs more often in those with diabetes, and weight loss can also lower the chance of adult-onset diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer mixed drug treatments. There are emerging targeted therapies that already are making an impact,” said a specialist.

For many people, however, education about this rare but {dev